Accuray (ARAY) Misses Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts ARAY Hot Sheet
Price: $0.15 +7.14%
Financial Fact:
Cost of products: 23.35M
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Cost of products: 23.35M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Accuray (NASDAQ: ARAY) reported Q3 EPS of ($0.10), $0.05 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $99.83 million versus the consensus estimate of $97.68 million.
For earnings history and earnings-related data on Accuray (ARAY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- NewLake Capital Partners, Inc. (NLCP) Misses Q2 EPS by 9c
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
